Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20

Detalhes bibliográficos
Ano de defesa: 2012
Autor(a) principal: NUNES, Paula Roberta lattes
Orientador(a): LACERDA, Elisângela de Paula Silveira lattes
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Goiás
Programa de Pós-Graduação: Mestrado em Ciências Farmacêuticas
Departamento: Ciências da Saúde - Farmácia
País: BR
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.bc.ufg.br/tede/handle/tde/2114
Resumo: The complex of gold K[Au(CN2)], for example, was introduced at the beginning of the twentieth century for the treatment of tuberculosis and then replaced for the gold thiolates (I), which were used in the decade of 30 for the treatment of Rheumatoid Arthritis. The exploration of gold complexes for the use as an anti-cancer agent, in an attempt to find a drug less toxic that cisplatin. The current study aimed to evaluate potential cytotoxic and genotoxic, as well as the mechanism of cell death of three new gold-based compounds, which is bioactive substance of synthetic origin, using different cell lines in vitro. In the cytotoxicity assay the effects of the three gold complexes were evaluated in four tumor cell lines (B16-F10, K562 and A20) and in two normal lines (L-929, MRC-5) through MTT test, the compounds at different concentrations (0.2, 2, 20, 50, 100, 200 μM) per 48 hours of treatment. The study was conducted to test electrophoresis on agarose gel at concentrations corresponding to IC50 of the strains tested. Were also performed cell cycle analysis and comet test. In statistical analysis for comparison between treated groups and control them, was used Anova, in a single criterion and Dunnet's Post-test (GraphPad Prism 3.02). The results obtained with MTT assay the tested strains MRC-5, L-929, B-16-F10, A20, K562, for the Spar Au compound was (104, 65.1, 45, 48.3, 61 2, respectively) for the Au Levo compound was (52.8, 181, 28.8, 48.9, 50, respectively) and the Au Nor compound was (65.1, 79.2, 26 6, 24.9, 55, respectively). After the screening of compounds, more specific tests were performed only with some strains that showed more promising results. For K562 cells and B16-F10 treated with Au Levo and Au Spar, respectively, observed that the test showed no degradation of DNA by apoptosis in the tests performed with 48 hours of treatment with the compounds. The line B16-F10 treated with the compound Au Spar did not significantly alter cell cycle kinetics and no reported significant damage to DNA after 48 hours of treatment. More specific tests have to be made in order to deepen the mechanism of cell death, since the tests were not enough to demonstrate how the compound is acting.
id UFG-2_c55484ed1ff834d1527f191e0b04651b
oai_identifier_str oai:repositorio.bc.ufg.br:tde/2114
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
repository_id_str
spelling LACERDA, Elisângela de Paula Silveirahttp://lattes.cnpq.br/9390789693192751http://lattes.cnpq.br/3030319030801535NUNES, Paula Roberta2014-07-29T16:11:50Z2012-08-312012-02-28NUNES, Paula Roberta. Study of cytotoxic, genotoxic and apoptotic complex of new gold (III) of fluoroquinolones against B16-F10 cells, K562 and A20. 2012. 100 f. Dissertação (Mestrado em Ciências da Saúde - Farmácia) - Universidade Federal de Goiás, Goiânia, 2012.http://repositorio.bc.ufg.br/tede/handle/tde/2114The complex of gold K[Au(CN2)], for example, was introduced at the beginning of the twentieth century for the treatment of tuberculosis and then replaced for the gold thiolates (I), which were used in the decade of 30 for the treatment of Rheumatoid Arthritis. The exploration of gold complexes for the use as an anti-cancer agent, in an attempt to find a drug less toxic that cisplatin. The current study aimed to evaluate potential cytotoxic and genotoxic, as well as the mechanism of cell death of three new gold-based compounds, which is bioactive substance of synthetic origin, using different cell lines in vitro. In the cytotoxicity assay the effects of the three gold complexes were evaluated in four tumor cell lines (B16-F10, K562 and A20) and in two normal lines (L-929, MRC-5) through MTT test, the compounds at different concentrations (0.2, 2, 20, 50, 100, 200 μM) per 48 hours of treatment. The study was conducted to test electrophoresis on agarose gel at concentrations corresponding to IC50 of the strains tested. Were also performed cell cycle analysis and comet test. In statistical analysis for comparison between treated groups and control them, was used Anova, in a single criterion and Dunnet's Post-test (GraphPad Prism 3.02). The results obtained with MTT assay the tested strains MRC-5, L-929, B-16-F10, A20, K562, for the Spar Au compound was (104, 65.1, 45, 48.3, 61 2, respectively) for the Au Levo compound was (52.8, 181, 28.8, 48.9, 50, respectively) and the Au Nor compound was (65.1, 79.2, 26 6, 24.9, 55, respectively). After the screening of compounds, more specific tests were performed only with some strains that showed more promising results. For K562 cells and B16-F10 treated with Au Levo and Au Spar, respectively, observed that the test showed no degradation of DNA by apoptosis in the tests performed with 48 hours of treatment with the compounds. The line B16-F10 treated with the compound Au Spar did not significantly alter cell cycle kinetics and no reported significant damage to DNA after 48 hours of treatment. More specific tests have to be made in order to deepen the mechanism of cell death, since the tests were not enough to demonstrate how the compound is acting.O complexo de ouro K[Au(CN)2], por exemplo, foi introduzido na virada do século XX para o tratamento da tuberculose e logo após substituído pelos tiolatos de ouro (I), que foram usados nos anos 30 para o tratamento da artrite reumatóide. A exploração de complexos de ouro para uso como agente anticâncer foi iniciada na tentativa de se obter uma droga menos tóxica que a cisplatina. O presente trabalho teve como objetivo avaliar o potencial citotóxico e genotóxico, assim como o mecanismo de morte celular de três novos compostos a base de ouro, que tem como substância bioativa de origem sintética utilizando diferentes linhagens celulares in vitro. No ensaio de citotoxicidade os efeitos dos três complexos de ouro foram avaliados frente quatro linhagens tumorais (B16-F10, K562 e A20) e duas linhagens normais (L-929 e MRC-5) através do teste de MTT, em diferentes concentrações dos compostos (0,2; 2; 20; 50; 100; 200 μM) por 48 horas de tratamento. Foi realizado para o estudo o ensaio de eletroforese em gel de agarose nas concentrações correspondentes a IC50 das linhagens testadas (Sambrook, 2001), foram realizados também análises de ciclo celular e teste cometa. Análise estatística para comparação entre os grupos tratados e controle foi utilizado Anova segundo um único critério e pós-teste Dunnet s (software GraphPad Prism V4). Os resultados obtidos através do ensaio de MTT frente às linhagens testadas MRC-5, L-929, B16- F10, A20 e K562 para o composto Au Spar foi (104; 65,1; 45; 48,3; 61,2, respectivamente) para o composto Au Levo foi (52,8; 181; 28,8; 48,9; 50, respectivamente) e para o composto Au Nor foi ( 65,1; 79,2; 26,6; 24,9; 55, respectivamente). Após a triagem dos compostos, testes mais específicos foram realizados apenas com algumas linhagens que apresentaram resultados mais promissores. Para a linhagem K562 e B16-F10 tratadas com Au Levo e Au Spar respectivamente, observou-se que no ensaio de degradação de DNA não apresentaram padrão de degradação por apoptose nos ensaios realizados com 48 h de tratamento com os compostos. A linhagem B16-F10 tratada com o composto Au Spar não alterou significativamente a cinética celular, além de não apresentar danos significativos ao DNA após 48 h de tratamento. Testes mais específicos devem ser realizados com a finalidade de aprofundar no mecanismo de morte das células, visto que os testes realizados não foi o bastante para demonstrar qual é a via pelo qual o composto está agindo.Made available in DSpace on 2014-07-29T16:11:50Z (GMT). No. of bitstreams: 1 Dissertacao Paula R Nunes.pdf: 2497503 bytes, checksum: 2a22fb8d4cdc25835230841f6fc7b21d (MD5) Previous issue date: 2012-02-28application/pdfhttp://repositorio.bc.ufg.br/TEDE/retrieve/4886/Dissertacao%20Paula%20R%20Nunes.pdf.jpgporUniversidade Federal de GoiásMestrado em Ciências FarmacêuticasUFGBRCiências da Saúde - FarmáciaComplexo de OuroAntitumoralApoptoseCitotoxidadeComplex of GoldApoptosisCytotoxicityCNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::CANCEROLOGIAEstudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20Study of cytotoxic, genotoxic and apoptotic complex of new gold (III) of fluoroquinolones against B16-F10 cells, K562 and A20info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGORIGINALDissertacao Paula R Nunes.pdfapplication/pdf2497503http://repositorio.bc.ufg.br/tede/bitstreams/c8bbcd8c-c4e2-44bc-9eac-3aa9a82f4a58/download2a22fb8d4cdc25835230841f6fc7b21dMD51THUMBNAILDissertacao Paula R Nunes.pdf.jpgDissertacao Paula R Nunes.pdf.jpgGenerated Thumbnailimage/jpeg4291http://repositorio.bc.ufg.br/tede/bitstreams/21d020d3-3924-431e-8aa1-64e9f554d65e/downloadb4d1b14b58ed178a72961eafc0e1d938MD52tde/21142014-07-30 03:17:19.536open.accessoai:repositorio.bc.ufg.br:tde/2114http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2014-07-30T06:17:19Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)false
dc.title.por.fl_str_mv Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20
dc.title.alternative.eng.fl_str_mv Study of cytotoxic, genotoxic and apoptotic complex of new gold (III) of fluoroquinolones against B16-F10 cells, K562 and A20
title Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20
spellingShingle Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20
NUNES, Paula Roberta
Complexo de Ouro
Antitumoral
Apoptose
Citotoxidade
Complex of Gold
Apoptosis
Cytotoxicity
CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::CANCEROLOGIA
title_short Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20
title_full Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20
title_fullStr Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20
title_full_unstemmed Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20
title_sort Estudo da atividade citotóxica, genotóxica e apoptótica de novos complexos de ouro (III) de fluorquinolonas frente às células B16-F10, K562 e A20
author NUNES, Paula Roberta
author_facet NUNES, Paula Roberta
author_role author
dc.contributor.advisor1.fl_str_mv LACERDA, Elisângela de Paula Silveira
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/9390789693192751
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/3030319030801535
dc.contributor.author.fl_str_mv NUNES, Paula Roberta
contributor_str_mv LACERDA, Elisângela de Paula Silveira
dc.subject.por.fl_str_mv Complexo de Ouro
Antitumoral
Apoptose
Citotoxidade
topic Complexo de Ouro
Antitumoral
Apoptose
Citotoxidade
Complex of Gold
Apoptosis
Cytotoxicity
CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::CANCEROLOGIA
dc.subject.eng.fl_str_mv Complex of Gold
Apoptosis
Cytotoxicity
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::CANCEROLOGIA
description The complex of gold K[Au(CN2)], for example, was introduced at the beginning of the twentieth century for the treatment of tuberculosis and then replaced for the gold thiolates (I), which were used in the decade of 30 for the treatment of Rheumatoid Arthritis. The exploration of gold complexes for the use as an anti-cancer agent, in an attempt to find a drug less toxic that cisplatin. The current study aimed to evaluate potential cytotoxic and genotoxic, as well as the mechanism of cell death of three new gold-based compounds, which is bioactive substance of synthetic origin, using different cell lines in vitro. In the cytotoxicity assay the effects of the three gold complexes were evaluated in four tumor cell lines (B16-F10, K562 and A20) and in two normal lines (L-929, MRC-5) through MTT test, the compounds at different concentrations (0.2, 2, 20, 50, 100, 200 μM) per 48 hours of treatment. The study was conducted to test electrophoresis on agarose gel at concentrations corresponding to IC50 of the strains tested. Were also performed cell cycle analysis and comet test. In statistical analysis for comparison between treated groups and control them, was used Anova, in a single criterion and Dunnet's Post-test (GraphPad Prism 3.02). The results obtained with MTT assay the tested strains MRC-5, L-929, B-16-F10, A20, K562, for the Spar Au compound was (104, 65.1, 45, 48.3, 61 2, respectively) for the Au Levo compound was (52.8, 181, 28.8, 48.9, 50, respectively) and the Au Nor compound was (65.1, 79.2, 26 6, 24.9, 55, respectively). After the screening of compounds, more specific tests were performed only with some strains that showed more promising results. For K562 cells and B16-F10 treated with Au Levo and Au Spar, respectively, observed that the test showed no degradation of DNA by apoptosis in the tests performed with 48 hours of treatment with the compounds. The line B16-F10 treated with the compound Au Spar did not significantly alter cell cycle kinetics and no reported significant damage to DNA after 48 hours of treatment. More specific tests have to be made in order to deepen the mechanism of cell death, since the tests were not enough to demonstrate how the compound is acting.
publishDate 2012
dc.date.available.fl_str_mv 2012-08-31
dc.date.issued.fl_str_mv 2012-02-28
dc.date.accessioned.fl_str_mv 2014-07-29T16:11:50Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv NUNES, Paula Roberta. Study of cytotoxic, genotoxic and apoptotic complex of new gold (III) of fluoroquinolones against B16-F10 cells, K562 and A20. 2012. 100 f. Dissertação (Mestrado em Ciências da Saúde - Farmácia) - Universidade Federal de Goiás, Goiânia, 2012.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tde/2114
identifier_str_mv NUNES, Paula Roberta. Study of cytotoxic, genotoxic and apoptotic complex of new gold (III) of fluoroquinolones against B16-F10 cells, K562 and A20. 2012. 100 f. Dissertação (Mestrado em Ciências da Saúde - Farmácia) - Universidade Federal de Goiás, Goiânia, 2012.
url http://repositorio.bc.ufg.br/tede/handle/tde/2114
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Mestrado em Ciências Farmacêuticas
dc.publisher.initials.fl_str_mv UFG
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Ciências da Saúde - Farmácia
publisher.none.fl_str_mv Universidade Federal de Goiás
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
instname_str Universidade Federal de Goiás (UFG)
instacron_str UFG
institution UFG
reponame_str Repositório Institucional da UFG
collection Repositório Institucional da UFG
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/c8bbcd8c-c4e2-44bc-9eac-3aa9a82f4a58/download
http://repositorio.bc.ufg.br/tede/bitstreams/21d020d3-3924-431e-8aa1-64e9f554d65e/download
bitstream.checksum.fl_str_mv 2a22fb8d4cdc25835230841f6fc7b21d
b4d1b14b58ed178a72961eafc0e1d938
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository.mail.fl_str_mv tasesdissertacoes.bc@ufg.br
_version_ 1793965603015360512